Factor VIIi inhibitor. Gruppo Italiano Coagulopatie Congenite
Ghirardini, A.; Schinaia, N.
Lancet 342(8879): 1110
1993
ISSN/ISBN: 0140-6736 PMID: 8105325 Document Number: 420864
Document emailed within 1 workday
Related Documents
Schinaia, N.; Ghirardini, A.M.; Mazzucconi, M.G.; Tagariello, G.; Morfini, M.; Chiarotti, F. 1994: Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite Thrombosis and Haemostasis 72(1): 33-38Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Richard, C.; Sedano, C.; Cuadrado, M.A.; Iriondo, A.; Bello, C.; Gandarillas, M.A.; Zubizarreta, A. 1986: Effect of a thymic factor on the concentration of a factor VIIi inhibitor in a patient with treated Hodgkin's disease Thrombosis and Haemostasis 55(2): 299-300
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Schoppmann, A.; Waytes, A.T. 1996: Factor VIIi inhibitor and severity of hemophilia Thrombosis and Haemostasis 76(2): 280-281
Dini, G.; Cancedda, R.; Giorgiani, G.; Porta, F.; Messina, C.; Uderzo, C.; Pession, A.; Fagioli, F.; La Nasa, G.; Arcese, W.; Pollichieni, S.; Zecca, M.; Lanino, E.; Mazzolari, E.; Cesaro, S.; Balduzzi, A.; Rondelli, R.; Vassallo, E.; Cappelli, B.; Locatelli, F. 2002: Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO) Haematologica 87(8 Suppl): 51-57
Reece, E.A.; Romero, R.; Hobbins, J. 1984: Coagulopathy associated with factor VIII inhibitor. A literature review Journal of Reproductive Medicine 29(1): 53-58
Kucharski, W.; Scharf, R.; Ziemski, J.M.; Jaśkowiak, W.; Lopaciuk, S.; Sikora, S.; Siekierski, P. 1997: Factor VIIi inhibitor appearing in women during delivery Ginekologia Polska 68(9): 402-406
Aledort, L.M. 1993: World registry on factor VIIi inhibitor patients: why? Seminars in Hematology 30(2 Suppl 1: 7-9
Eckstein, A.; Voss, B.; Taubert, W.; Scheja, J. 1986: A rare case of factor VIII-inhibitor formation Deutsche Zahnarztliche Zeitschrift 41(4): 398-399
Akahori, M.; Yamane, T.; Hino, M.; Ohta, K.; Takubo, T.; Samori, T.; Tatsumi, N. 1999: Non-hemophilic patient with inhibitor against factor VIIi produced after the second delivery Rinsho Byori. Japanese Journal of Clinical Pathology 47(9): 891-895
Carreras, L.O.; Perez, G.N.; Xavier, D.L.; Blanco, A.N.; Penalva, L.B. 1988: Autoimmune factor VIIi inhibitor responsive to gammaglobulin without in vitro neutralisation Thrombosis and Haemostasis 60(2): 343
Gobbi, P.G.; Pieresca, C.; Cavanna, L.; Corbella, F.; Vallisa, D.; Federico, M.; Formisano, R.; Carotenuto, M.; Merli, F.; Callea, V.; Angrilli, F.; Silingardi, V. 1996: CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. a prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) Haematologica 81(6): 503-512
Tham, C.J.; Trew, M.; Brager, N. 1999: Abnormal clotting and production of factor VIIi inhibitor in a patient treated with venlafaxine Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(9): 923-924
Mafrici, A.; Mauri, F.; Maggioni, A.P.; Franzosi, M.G.; Santoro, L.; De Vita, C. 1995: Atenolol I.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. the GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico Giornale Italiano di Cardiologia 25(3): 353-364